How much does abcellera biologics make a year?

AbCellera Biologics (NASDAQ:ABCL) has a recorded annual revenue of $485.42 million. How much profit does AbCellera Biologics generate each year? AbCellera Biologics (NASDAQ:ABCL) has a recorded net income of $118.92 million. ABCL has generated $0.50 earnings per share over the last four quarters.

How did abcellera biologics (ABCL) perform in the quarter ended December 2023?

AbCellera Biologics Inc. (ABCL) reported $9.18 million in revenue for the quarter ended December 2023, representing a year-over-year decline of 57.4%. EPS of -$0.17 for the same period compares to -$0.10 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $9.58 million, representing a surprise of -4.19%.

What is abcellera biologics's next earnings release date?

AbCellera Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2023 based off last year's report dates. Learn more on ABCL's earnings history. Did AbCellera Biologics beat their earnings estimates last quarter?